Revealing combined pathology of genitals, mammary and thyroid glands with sonographic screening
- 作者: Domansky V.Y.1, Tsvetkova N.V.1, Kulyushina E.A.1, Dmitriev S.G.1
-
隶属关系:
- Tver State Medical Academy
- 期: 卷 48, 编号 5S (1999)
- 页面: 56-56
- 栏目: Articles
- ##submission.dateSubmitted##: 16.02.2022
- ##submission.dateAccepted##: 16.02.2022
- ##submission.datePublished##: 15.12.1999
- URL: https://journals.eco-vector.com/jowd/article/view/100869
- DOI: https://doi.org/10.17816/JOWD100869
- ID: 100869
如何引用文章
全文:
详细
Objective. To study revelation rate of a combined pathology of genitals, thyroid and mammary glands among the conditionally healthy women with sonographic screening.
全文:
Objective. To study revelation rate of a combined pathology of genitals, thyroid and mammary glands among the conditionally healthy women with sonographic screening.
Methods. Sonographic screening of 1674 women aged 17-81 was performed. The mean age was 39 years. The examination was made with MED IS ON SA-1500/SA-4800 using 3,5 and 7,5 MHz transducers and 6,5 MHz transvaginal transducer.
Results. The pathology was revealed in 968 women that have made 57,8% from number surveyed. Among them, the combined pathology was found out much more often than isolated. So, from 776 revealed cases of gynecologic pathology, isolated pathology was only in 263 (33,9%), from 353 pathologic findings in mammary glands — in 91 (25,4%), from 397 cases of thyroid gland pathology — in 141 (37,3%). In total, from 1526 pathological conditions only 495 had no combinations with other pathologies, that has made 32,4%. Another 1031 were diagnosed in 473 patients. Most frequent components of combinations were endometriosis (88,4%), endometrial hyperplasia (89,7%), sclerocystic degeneration of ovaries (85,7%), lactocele (90,3%), mammary fibrocystic disease (73,2%), and thyroiditis (80,0%).
Conclusions. Performing a sonographic screening it is necessary to carry out a complex examination, and when one disease is revealed it is advisable to seek an associated pathology for the adequate determination of the further treatment tactics.
作者简介
V. Domansky
Tver State Medical Academy
编辑信件的主要联系方式.
Email: info@eco-vector.com
俄罗斯联邦, Tver
N. Tsvetkova
Tver State Medical Academy
Email: info@eco-vector.com
俄罗斯联邦, Tver
E. Kulyushina
Tver State Medical Academy
Email: info@eco-vector.com
俄罗斯联邦, Tver
S. Dmitriev
Tver State Medical Academy
Email: info@eco-vector.com
俄罗斯联邦, Tver
参考
补充文件
![](/img/style/loading.gif)